--- title: "BIOTECHNOLOGY VALUE FUND II LP — Ownership Dossier" canonical: https://whiteintel.dev/entity/9ff49e18-8ece-51e1-9f80-9949902ef4c8 json: https://whiteintel.dev/api/public/dossier/9ff49e18-8ece-51e1-9f80-9949902ef4c8 identifier: sec:0001102444 jurisdiction: US risk: Low source: WhiteIntel corporate-ownership graph --- # BIOTECHNOLOGY VALUE FUND II LP **Type:** Person **Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us) **Identifier:** `sec:0001102444` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/9ff49e18-8ece-51e1-9f80-9949902ef4c8 **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/9ff49e18-8ece-51e1-9f80-9949902ef4c8 ## Ownership & control ### Holdings / subsidiaries - **XOMA Royalty Corp** (10% owner) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673 - **Olema Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729 - **AEOLUS PHARMACEUTICALS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/519998d9-2ce7-59e5-b7ac-34784ff68e61 - **ADVANCED MAGNETICS INC** (other) — https://whiteintel.dev/entity/d29e63ca-24a2-58f4-8912-115eb4b05d47 - **XOMA Royalty Corp** (tenpercentowner) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673 - **MoonLake Immunotherapeutics** (other) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934 - **Olema Pharmaceuticals, Inc.** (other) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729 - **MoonLake Immunotherapeutics** (tenpercentowner) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934 - **Kymera Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7 - **Olema Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729 - **MoonLake Immunotherapeutics** (director) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934 - **Kymera Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7 - **IMMUNIC, INC.** (director) — https://whiteintel.dev/entity/2e503801-64a9-5687-a6d5-8453384d5c51 - **Repare Therapeutics Inc.** (other) — https://whiteintel.dev/entity/a4f328c3-615d-5e8c-a160-a31e92a6143d - **IMMUNIC, INC.** (other) — https://whiteintel.dev/entity/2e503801-64a9-5687-a6d5-8453384d5c51 - **ESSA PHARMA INC.** (other) — https://whiteintel.dev/entity/a496bea7-7d30-5e59-8841-ba61e99e06cf - **Allakos Inc.** (other) — https://whiteintel.dev/entity/5439ff82-19b3-51bc-9ac4-c6f7101c71e3 - **CRESCENT BIOPHARMA, INC.** (other) — https://whiteintel.dev/entity/af95539c-09bd-5667-a03e-8cd2e3451859 - **Third Harmonic Bio, Inc.** (other) — https://whiteintel.dev/entity/e1b6fe48-1324-5dbb-bd90-38bb4c119af2 - **4D Molecular Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/d72c9d0a-737e-53ec-b488-9dc05920e9a3 - **PALVELLA THERAPEUTICS, INC.** (other) — https://whiteintel.dev/entity/3ef13500-65c6-5a7a-bc7c-5944649c1abb - **Eledon Pharmaceuticals, Inc.** (other) — https://whiteintel.dev/entity/52b9f178-e91f-55f5-9c71-d0920cd35871 - **RAIN ONCOLOGY INC.** (director) — https://whiteintel.dev/entity/54053b30-6edd-583c-8763-b27cba56a7cd - **RAIN ONCOLOGY INC.** (other) — https://whiteintel.dev/entity/54053b30-6edd-583c-8763-b27cba56a7cd - **POINT BIOPHARMA GLOBAL INC.** (other) — https://whiteintel.dev/entity/43e8e7b1-fb25-50ef-88ea-ea634f8c1919 - **enGene Holdings Inc.** (other) — https://whiteintel.dev/entity/c9dc64b2-8894-5ef5-a845-77724013327b - **Repare Therapeutics Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a4f328c3-615d-5e8c-a160-a31e92a6143d - **CELL THERAPEUTICS INC** (other) — https://whiteintel.dev/entity/818d7969-e7e1-55ba-b25f-9085b030a3bf - **Structure Therapeutics Inc.** (other) — https://whiteintel.dev/entity/4d402256-4ab9-5146-a9e3-6950aee1cf14 - **XOMA Royalty Corp** (director) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673 - **CELL THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/818d7969-e7e1-55ba-b25f-9085b030a3bf - **Cullinan Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da - **RAIN ONCOLOGY INC.** (directorother) — https://whiteintel.dev/entity/54053b30-6edd-583c-8763-b27cba56a7cd - **Kymera Therapeutics, Inc.** (directorother) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7 - **CELL THERAPEUTICS INC** (directorother) — https://whiteintel.dev/entity/818d7969-e7e1-55ba-b25f-9085b030a3bf - **Olema Pharmaceuticals, Inc.** (directorother) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729 - **Verastem, Inc.** (other) — https://whiteintel.dev/entity/48e38b21-bb92-51a5-bacf-892c060d8dd6 - **Merus N.V.** (other) — https://whiteintel.dev/entity/94da0ca6-a73e-5895-83fb-b50de1f38026 - **FIVE PRIME THERAPEUTICS INC** (other) — https://whiteintel.dev/entity/9aff28e2-4669-58d2-ac70-a8796893d4c8 - **CytomX Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/6548f99c-6754-59ef-a2b1-ed7cd21f6d1b - **IDEAYA Biosciences, Inc.** (other) — https://whiteintel.dev/entity/740ea9d8-4732-5954-9126-66106b8f76b5 - **DISCOVERY PARTNERS INTERNATIONAL INC** (other) — https://whiteintel.dev/entity/3ae609cf-fccd-58c2-960d-ef36bf02bf22 - **CYTOKINETICS INC** (other) — https://whiteintel.dev/entity/0eb385f6-49c6-5406-ba0c-13179011e29b - **PRINCIPIA BIOPHARMA INC.** (other) — https://whiteintel.dev/entity/6a36d913-a2d3-50be-abc9-858acd647053 - **CALITHERA BIOSCIENCES, INC.** (other) — https://whiteintel.dev/entity/62e5aa07-2012-5418-a486-e6d032e5e66f - **XOMA Royalty Corp** (other) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673 - **CONCERT PHARMACEUTICALS INC** (other) — https://whiteintel.dev/entity/3e2da9ca-0d84-5cb7-9b84-e4195d1748f4 - **IMMUNE DESIGN CORP.** (other) — https://whiteintel.dev/entity/90dcaf96-fc16-5591-8d81-164c9a7e0cff - **DISCOVERY PARTNERS INTERNATIONAL INC** (tenpercentowner) — https://whiteintel.dev/entity/3ae609cf-fccd-58c2-960d-ef36bf02bf22 - **Syndax Pharmaceuticals Inc** (other) — https://whiteintel.dev/entity/6bf1b313-1d8f-5b91-99ed-9315f51eef71 - **ARQULE INC** (other) — https://whiteintel.dev/entity/fd5da0c7-0a00-5a43-af99-33ea05777d0a - **Xenon Pharmaceuticals Inc.** (other) — https://whiteintel.dev/entity/3e20a2da-c4ad-5d3e-8c87-9dd6b2938172 - **Regulus Therapeutics Inc.** (other) — https://whiteintel.dev/entity/4fb1e8db-c587-5dce-8215-4c53445c8050 - **CAPSTONE HOLDING CORP.** (other) — https://whiteintel.dev/entity/3d6d5bef-2320-59cb-8b5b-f754dd342faa - **ALPINE IMMUNE SCIENCES, INC.** (other) — https://whiteintel.dev/entity/ad945a36-f186-59fa-b801-2b39506284f6 - **BIOMIRA CORP** (tenpercentowner) — https://whiteintel.dev/entity/82b3cb4c-4e01-50d7-99f6-0eb90587fb53 - **BIOMIRA CORP** (other) — https://whiteintel.dev/entity/82b3cb4c-4e01-50d7-99f6-0eb90587fb53 - **CHEMOCENTRYX, INC.** (other) — https://whiteintel.dev/entity/70c0c142-20ba-563e-bce9-2589a7d91f7f - **GYRE THERAPEUTICS, INC.** (other) — https://whiteintel.dev/entity/7dfebd22-337b-5e27-94f0-3c78e5f6b0fe - **ARRAY BIOPHARMA INC** (other) — https://whiteintel.dev/entity/cab587d3-0505-5e86-8bf0-3570c5c76926 - **INTERFILM INC** (other) — https://whiteintel.dev/entity/2f6cdcf9-82d9-59cd-9857-fe92550c6e3b - **REGADO BIOSCIENCES INC** (other) — https://whiteintel.dev/entity/bfb2862c-0175-5185-b1f6-3650d90887de - **LIGAND PHARMACEUTICALS INC** (other) — https://whiteintel.dev/entity/e2911e68-d132-5192-86b6-b4f7b7e7b48c - **RIGEL PHARMACEUTICALS INC** (other) — https://whiteintel.dev/entity/d86958a6-7ca3-521c-887c-e574ee5ee40b - **NEUROCRINE BIOSCIENCES INC** (other) — https://whiteintel.dev/entity/3edd6842-e439-5576-bbae-f7c754e45400 - **CORTECH INC** (other) — https://whiteintel.dev/entity/1796b596-c7bb-5635-9c48-765c776826d5 - **ICAGEN INC** (other) — https://whiteintel.dev/entity/8bb5d6ec-5781-5fdd-9c3f-f7fb56b4f2c3 - **CELERA CORP** (other) — https://whiteintel.dev/entity/a23c01a9-33f3-5ffd-b7dd-37c06f0d4431 - **CELERA CORP** (tenpercentowner) — https://whiteintel.dev/entity/a23c01a9-33f3-5ffd-b7dd-37c06f0d4431 - **ASTEX PHARMACEUTICALS, INC** (other) — https://whiteintel.dev/entity/07d83f27-fdb3-52c2-bf10-b983a720f0c5 - **ABBOTT BIOTHERAPEUTICS CORP** (other) — https://whiteintel.dev/entity/0cc7647d-818e-5166-83ba-f7236fd5d0ef - **MEDICINOVA INC** (tenpercentowner) — https://whiteintel.dev/entity/509a5353-a9b6-5fe9-9c1e-83fe30478bad - **NEUROBIOLOGICAL TECHNOLOGIES INC /CA/** (other) — https://whiteintel.dev/entity/c0511b15-3b31-5861-8bad-81f02319f12f - **AVIGEN INC \DE** (other) — https://whiteintel.dev/entity/ff9537a4-e5b8-5bd3-bb30-4cdac1f1a954 - **COMBINATORX INC** (other) — https://whiteintel.dev/entity/ebcb95b8-c7e4-5779-b5e7-29ce6029d873 - **GYRE THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/7dfebd22-337b-5e27-94f0-3c78e5f6b0fe - **REPLIGEN CORP** (other) — https://whiteintel.dev/entity/4ce5eb5b-578a-5c94-946c-97af4791a7cf - **ABBOTT BIOTHERAPEUTICS CORP** (tenpercentowner) — https://whiteintel.dev/entity/0cc7647d-818e-5166-83ba-f7236fd5d0ef - **DYNAVAX TECHNOLOGIES CORP** (other) — https://whiteintel.dev/entity/226cb0cf-11f9-5e28-9899-679e83adaa5b - **ADOLOR CORP** (other) — https://whiteintel.dev/entity/5a9fb915-ed75-5410-8809-88dae879266c - **REPLIGEN CORP** (tenpercentownerother) — https://whiteintel.dev/entity/4ce5eb5b-578a-5c94-946c-97af4791a7cf - **CURIS INC** (other) — https://whiteintel.dev/entity/1a33a73a-f742-5c84-a280-d005afd86251 - **INHIBITEX INC** (tenpercentownerother) — https://whiteintel.dev/entity/57dfdc73-dc22-5f33-9233-1939884a3e2e - **LIGAND PHARMACEUTICALS INC** (tenpercentownerother) — https://whiteintel.dev/entity/e2911e68-d132-5192-86b6-b4f7b7e7b48c - **CURIS INC** (tenpercentownerother) — https://whiteintel.dev/entity/1a33a73a-f742-5c84-a280-d005afd86251 - **PHARMACOPEIA DRUG DISCOVERY INC** (tenpercentownerother) — https://whiteintel.dev/entity/02858e73-ac25-57f0-b020-6191e901991a - **AVIGEN INC \DE** (tenpercentownerother) — https://whiteintel.dev/entity/ff9537a4-e5b8-5bd3-bb30-4cdac1f1a954 - **COMBINATORX INC** (tenpercentownerother) — https://whiteintel.dev/entity/ebcb95b8-c7e4-5779-b5e7-29ce6029d873 - **DYNAVAX TECHNOLOGIES CORP** (tenpercentownerother) — https://whiteintel.dev/entity/226cb0cf-11f9-5e28-9899-679e83adaa5b - **CAPSTONE HOLDING CORP.** (tenpercentownerother) — https://whiteintel.dev/entity/3d6d5bef-2320-59cb-8b5b-f754dd342faa - **PHARMACOPEIA DRUG DISCOVERY INC** (other) — https://whiteintel.dev/entity/02858e73-ac25-57f0-b020-6191e901991a - **ADOLOR CORP** (tenpercentownerother) — https://whiteintel.dev/entity/5a9fb915-ed75-5410-8809-88dae879266c - **NPS PHARMACEUTICALS INC** (other) — https://whiteintel.dev/entity/3df1e359-a084-5e9c-9619-abcb1e2224dd - **SGX PHARMACEUTICALS, INC.** (other) — https://whiteintel.dev/entity/9bf4a385-0d53-546d-888a-846029514afe - **SGX PHARMACEUTICALS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/9bf4a385-0d53-546d-888a-846029514afe - **NEUROBIOLOGICAL TECHNOLOGIES INC /CA/** (tenpercentownerother) — https://whiteintel.dev/entity/c0511b15-3b31-5861-8bad-81f02319f12f - **ARQULE INC** (tenpercentownerother) — https://whiteintel.dev/entity/fd5da0c7-0a00-5a43-af99-33ea05777d0a - **ASTEX PHARMACEUTICALS, INC** (tenpercentownerother) — https://whiteintel.dev/entity/07d83f27-fdb3-52c2-bf10-b983a720f0c5 - **NEUROCRINE BIOSCIENCES INC** (tenpercentownerother) — https://whiteintel.dev/entity/3edd6842-e439-5576-bbae-f7c754e45400 - **NPS PHARMACEUTICALS INC** (tenpercentownerother) — https://whiteintel.dev/entity/3df1e359-a084-5e9c-9619-abcb1e2224dd - **VIACELL INC** (other) — https://whiteintel.dev/entity/7637cd8c-a821-564c-8ef3-9a2aca991e4e - **VIACELL INC** (tenpercentowner) — https://whiteintel.dev/entity/7637cd8c-a821-564c-8ef3-9a2aca991e4e - **AEOLUS PHARMACEUTICALS, INC.** (tenpercentownerother) — https://whiteintel.dev/entity/519998d9-2ce7-59e5-b7ac-34784ff68e61 --- _This is the markdown-for-agents view of the WhiteIntel dossier for **BIOTECHNOLOGY VALUE FUND II LP**. Human view: https://whiteintel.dev/entity/9ff49e18-8ece-51e1-9f80-9949902ef4c8 · Structured JSON: https://whiteintel.dev/api/public/dossier/9ff49e18-8ece-51e1-9f80-9949902ef4c8._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._